Transaction #33952 · Form 4 · 0001193125-26-426668
Solid Biosciences Inc. · Exercise / conversion · Common Stock
Solid Biosciences Inc. · Transacted October 18, 2026 · Filed October 20, 2026
What does this filing report?
An SEC Form 4 filing for Solid Biosciences Inc. records an exercise / conversion involving Common Stock on October 18, 2026. The reported quantity was 9,750. The filing date is October 20, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Solid Biosciences Inc.
- Company CIK
- 0001707502
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 9,750
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 101,615
- Ownership description
- Not reported
- SEC acceptance time
- Oct 20, 2026, 4:05 PM EDT
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Brooks Gabriel ↗
Chief Medical Officer
CIK 0001997809
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- F2
- Includes 2,399 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 29, 2026.
- F3
- This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks.
- F4
- The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.